Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Reneo Pharmaceuticals Inc (RPHM)

Reneo Pharmaceuticals Inc (RPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million GlobeNewswire - Fri Oct 4, 2024

RPHM : 1.8200 (+5.20%)
OKUR : 4.73 (-10.25%)
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure GlobeNewswire - Wed Oct 2, 2024

RPHM : 1.8200 (+5.20%)
Shortened Week Due to Easter Holiday Baystreet - Fri Mar 22, 2024

Monday U.S.Economic Lookahead New home sales (Feb.)Featured EarningsPVH Corp. (NYSE: ...

AEZS.TO : 8.29 (+8.08%)
PVH : 91.64 (+0.22%)
MKC : 50.24 (-1.18%)
RPHM : 1.8200 (+5.20%)
OXM : 42.53 (-0.72%)
MSM : 102.63 (+0.35%)
PRGS : 28.95 (+3.95%)
CCL : 26.66 (+0.57%)
NOVC.TO : 1.75 (unch)
ANRG.TO : 3.14 (-0.95%)
PAYX : 93.02 (+0.42%)
WBA : 11.98 (+0.50%)
Reneo Pharmaceuticals Reports Second Quarter 2022 Financial Results Globe Newswire - Tue Aug 9, 2022

IRVINE, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the...

RPHM : 1.8200 (+5.20%)
Reneo Pharmaceuticals Appoints Roshawn Blunt to its Board of Directors Globe Newswire - Tue Aug 2, 2022

IRVINE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8200 (+5.20%)
Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates Globe Newswire - Tue Jul 26, 2022

LC-FAOD program to move forward into the next stage of clinical developmentEnrollment of pivotal STRIDE study in primary mitochondrial myopathies (PMM)...

RPHM : 1.8200 (+5.20%)
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Mon Jul 11, 2022

IRVINE, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8200 (+5.20%)
Reneo Pharmaceuticals Reports First Quarter 2022 Financial Results Globe Newswire - Tue May 10, 2022

IRVINE, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8200 (+5.20%)

Barchart Exclusives

McDonald’s Is Down 4% and Starbucks Is Up 25% in 2026. The Better Dividend Stock Might Surprise You. Barchart - Fri May 1, 6:00PM CDT
Starbucks is up 25% in 2026 while McDonald's slipped 4%. So why might McDonald's still be the smarter dividend buy? The numbers tell a story most investors are missing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.